| --- |
| pretty_name: CDC NREVSS — weekly RSV test specimens and positives |
| license: other |
| size_categories: |
| - 10K<n<100K |
| tags: |
| - cadence-weekly |
| - geo-us |
| - surveillance-respiratory |
| - pathogen-rsv |
| - tier-2 |
| - availability-open |
| schema_version: '0.1' |
| source_id: cdc-nrevss-rsv |
| source_url: https://www.cdc.gov/nrevss/php/dashboard/index.html |
| manifest_section: §1.6 |
| surveillance_category: respiratory |
| pathogens: |
| - rsv |
| availability: open |
| availability_notes: null |
| access_type: socrata |
| tier: 2 |
| cadence: weekly |
| geography_levels: |
| - subnational-region |
| geography_countries: |
| - US |
| gold_standard_for: [] |
| vintaged_version_of: null |
| succeeds: null |
| derived_from: [] |
| value_columns: |
| - name: rsvpos |
| unit: specimens/week |
| value_type: incident |
| description: Specimens testing positive for RSV (this test type, this region, this week) |
| aggregation: sum |
| - name: rsvtest |
| unit: specimens/week |
| value_type: incident |
| description: Total specimens tested for RSV |
| aggregation: sum |
| notes: |
| extra_columns: |
| - column: testtype |
| description: '`Antigen` or `PCR`. Always 2 rows per (date, region) — one per test type. Treat as a row-level dimension; |
| downstream % positive is computed per testtype.' |
| - column: outlier |
| description: 1 = source itself flagged this point as an outlier (excluded from CDC's published trend). |
| - column: location_name |
| description: '`HHS N` for traceability. `location_id` (`US-HHS-N`) is canonical.' |
| interpretation_caveats: |
| - column: rsvtest |
| caveat: PCR vs antigen counts are NOT comparable. PCR ramped up post-2018; antigen has been the long-term backbone but |
| is less sensitive. Don't sum across testtype — they're parallel signals. |
| general: 'NREVSS is the long-running multi-pathogen lab network. The full system covers flu, |
| |
| RSV, parainfluenza, hMPV, adenovirus, etc.; this Socrata view exposes only the |
| |
| RSV portion. Other pathogens are in sibling Socrata datasets (separate ingests). |
| |
| ' |
| extra: |
| pathogens_in_sibling_datasets: |
| - influenza-a/b → fluview_clinical (Delphi) |
| - hMPV / adenovirus / parainfluenza → separate Socrata ids |
| source_columns_omitted: 1 (`season` — derivable from `date`) |
| computed: |
| last_ingested: '2026-04-26T12:48:35Z' |
| row_count: 10313 |
| time_coverage: |
| - start: '2010-07-10' |
| end: '2020-06-27' |
| geography_unit_count: 10 |
| observed_cadence_days: 7 |
| missing_gaps: [] |
| data_hash: 1fc350efdd47a8f5 |
| --- |
| |
| # CDC NREVSS — weekly RSV test specimens and positives |
|
|
| NREVSS is the long-running multi-pathogen lab network. The full system covers flu, |
| RSV, parainfluenza, hMPV, adenovirus, etc.; this Socrata view exposes only the |
| RSV portion. Other pathogens are in sibling Socrata datasets (separate ingests). |
|
|
| **Source:** <https://www.cdc.gov/nrevss/php/dashboard/index.html> |
|
|
| ## Coverage |
|
|
| - **Time:** 2010-07-10 → 2020-06-27 |
| - **Cadence:** `weekly` (observed median spacing: 7 days) |
| - **Geography levels:** `subnational-region` — 10 unique location IDs |
| - **Countries:** US |
| - **Pathogens:** `rsv` |
| - **Surveillance category:** `respiratory` |
| - **Rows:** 10,313 |
|
|
| ## Columns |
|
|
| | Column | Unit | value_type | Aggregation | Description | |
| |--------|------|------------|-------------|-------------| |
| | `rsvpos` | specimens/week | `incident` | `sum` | Specimens testing positive for RSV (this test type, this region, this week) | |
| | `rsvtest` | specimens/week | `incident` | `sum` | Total specimens tested for RSV | |
| |
| ### Additional data columns |
| |
| - **`testtype`** — `Antigen` or `PCR`. Always 2 rows per (date, region) — one per test type. Treat as a row-level dimension; downstream % positive is computed per testtype. |
| - **`outlier`** — 1 = source itself flagged this point as an outlier (excluded from CDC's published trend). |
| - **`location_name`** — `HHS N` for traceability. `location_id` (`US-HHS-N`) is canonical. |
|
|
| ## Interpretation caveats |
|
|
| Things that may differ from how other sources define a similar measure. If you're combining this dataset with another, read these first. |
|
|
| - **`rsvtest`** — PCR vs antigen counts are NOT comparable. PCR ramped up post-2018; antigen has been the long-term backbone but is less sensitive. Don't sum across testtype — they're parallel signals. |
|
|
| ## Access |
|
|
| - **Availability:** `open` |
| - **Access type:** `socrata` |
| - **License:** other |
| - **Tier:** 2 |
|
|
| --- |
|
|
| *Schema version `0.1` · Last ingested 2026-04-26T12:48:35Z · `source_id: cdc-nrevss-rsv` · Manifest section §1.6* |
|
|
